跳至主要内容
临床试验/NCT03949335
NCT03949335已完成不适用

Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular Lens

Johnson & Johnson Surgical Vision, Inc.30 个研究点 分布在 1 个国家目标入组 272 人开始时间: 2019年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
272
试验地点
30
主要终点
Distance-Corrected Near Visual Acuity (DCNVA) at 40 cm

研究概览

简要总结

This study will be a prospective, multicenter, bilateral, comparative, three-way masked (Sponsor, subject and evaluator), randomized clinical investigation conducted at up to 15 sites. Up to 300 subjects will be enrolled to achieve approximately 270 bilaterally implanted subjects, resulting in approximately 244 evaluable subjects (122 per lens group) at 6 months. After informed consent is obtained and confirmation that all eligibility criteria are met, the eye(s) may be treated according to randomization.

After signing the informed consent form, subjects meeting all eligibility criteria will be randomized in a masked fashion to a treatment group: either the investigational IOL Model ZFR00V or the control IOL Model ZCB00. Prior to randomization, the investigator will choose which eye to operate on first for each subject at his/her discretion based on his/her standard clinical practice (e.g., the eye with the worse cataract, poorer best corrected distance vision and/or more severe optical/visual complaints). All subjects are intended to have bilateral cataract surgery with the second eye surgery occurring after the 1-week postoperative exam for the first eye, but no more than 30 days after the first eye surgery. All subjects will be examined through 6 months postoperatively according to the visit schedule

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Only the surgeon and the operative staff will know which lens type is implanted and will be unmasked throughout the study. There may also be site coordinators and other site study staff, such as those performing slit-lamp exams, who will be unmasked. Unmasked study staff and study subjects will be instructed not to disclose the lens type the subject received or to talk about the lens to any subjects or masked evaluators.

The subjects and the study technicians performing the postoperative vision tests are to be masked through study completion. To maintain subject/technician-masking through the 6-month study exams, a masking plan will be tailored for each site to detail how lens assignment information will be concealed from masked technicians.

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be at least 22 years old
  • have cataracts in both eyes
  • sign the written informed consent
  • be willing and able to comply with examination procedures
  • understand, read and write English to complete informed consent and questionnaires
  • be available for study follow-up visits

排除标准

  • currently participating in any other clinical study or have participated in a clinical study during the last 60 days
  • have a certain disease/illness such as poorly-controlled diabetes
  • have certain ocular conditions such as uncontrolled glaucoma
  • Is taking medication that may affect vision
  • Subject is pregnant, plan to become pregnant during the study, or is breastfeeding

结局指标

主要结局

Distance-Corrected Near Visual Acuity (DCNVA) at 40 cm

时间窗: 6 months (postoperative)

mean photopic monocular Distance Corrected Near Visual Acuity results at 40 cm for ZFR00 and control first eyes in the safety population at 6 months

次要结局

  • Monocular Distance-Corrected Defocus Curve(6 months postoperative)
  • Spectacle Wear(6 months postoperative)
  • Monocular Distance-Corrected Near Visual Acuity at 33 cm(6 months postoperative)
  • Monocular Distance-Corrected Intermediate Visual Acuity at 66 cm(6 months (postoperative))
  • Monocular Photopic Best-Corrected Distance Visual Acuity(6 months postoperative)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (30)

Loading locations...

相似试验

Clinical Investigation of the Safety and... | 临床试验